Genetic Engineering in Livestock

New Applications and Interdisciplinary Perspectives

  • Margret Engelhard
  • Kristin Hagen
  • Mathias Boysen

Part of the Ethics of Science and Technology Assessment book series (ETHICSSCI, volume 34)

Table of contents

  1. Front Matter
    Pages I-XV
  2. Heiner Niemann, Wilfried Kues, Joseph W. Carnwath
    Pages 1-30
  3. Louis-Marie Houdebine
    Pages 31-48
  4. Cornelis G. Van Reenen
    Pages 119-143

About this book


Recently, the first "zoopharming" product has reached market approval: it is a recombinant human protein for medical use that is produced in the milk of transgenic goats. In addition, other transgenic animals, including faster-growing salmon and „environmentally friendly" pigs with reduced levels of phosphate in their faeces are awaiting regulatory approval. These are only some examples of upcoming applications of genetic engineering in farm animals. Other potential applications include traditional breeding goals such as higher milk or meat yields, leaner meat, and disease resistance. While genetic engineering in livestock opens a huge range of possibilities, it also brings about concerns of safety and justification: does genetic engineering affect animal welfare? Is it safe and morally acceptable to apply genetic engineering to farm animals for the various purposes that are envisaged?

It is against this background that the Europäische Akademie GmbH and the Berlin-Brandenburgische Akademie der Wissenschaften addressed the topic of transgenic farm animals in an interdisciplinary symposium in 2007. In these proceedings the following topics are covered: an analysis of the state of the art of the technology and its applications, an introduction to the specific application zoopharming (including its historical industrial development and the market for biopharmaceuticals), an assessment of ethical aspects, and considerations regarding the investigation of animal welfare implications of livestock biotechnology. The proceedings address science, industry, politics and the general public interested in the chances and risks of this upcoming field of biotechnology.


Pharming biomedicine biotechnology genetic engineering protein transgen

Editors and affiliations

  • Margret Engelhard
    • 1
  • Kristin Hagen
    • 1
  • Mathias Boysen
    • 2
  1. 1.Europäische Akademie GmbH53474 Bad Neuenahr-AhrweilerGermany
  2. 2.Berlin-Brandenburgische Akademie derWissenschaftenGermany

Bibliographic information

  • DOI
  • Copyright Information Springer Berlin Heidelberg 2009
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Engineering Engineering (R0)
  • Print ISBN 978-3-540-85842-3
  • Online ISBN 978-3-540-85843-0
  • Series Print ISSN 1860-4803
  • Buy this book on publisher's site